Establishment Labs Holdings Stock News

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally i

CP, HALO, AMX, ESTA, and GEO have been added to the Zacks Rank #5 (Strong Sell) List on January 13, 2021.

CP, HALO, AMX, ESTA, and GEO have been added to the Zacks Rank #5 (Strong Sell) List on January 13, 2021.

ASH, CAH, and ESTA have been added to the Zacks Rank #5 (Strong Sell) List on January 12, 2022

ASH, CAH, and ESTA have been added to the Zacks Rank #5 (Strong Sell) List on January 12, 2022

Establishment Labs Holdings <> reports fourth quarter preliminary revenue to be in the range of $35-$35.5M (+30% to +32% Y/Y) vs

Credit Suisse AG bought a new stake in Establishment Labs Holdings Inc. (NASDAQ:ESTA) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 14,402 shares of the companys stock, valued at approximately $1,258,000. Credit Suisse AG owned 0.06% of Establishment Labs as []

Establishment Labs Holdings Inc. (NASDAQ:ESTA) shares were down 5.8% during trading on Friday . The company traded as low as $60.32 and last traded at $60.32. Approximately 2,265 shares traded hands during trading, a decline of 98% from the average daily volume of 99,694 shares. The stock had previously closed at $64.05. A number of []

Establishment Labs Holdings Inc. (NASDAQ:ESTA) shares saw unusually-high trading volume on Thursday . Approximately 30,109 shares were traded during mid-day trading, a decline of 63% from the previous sessions volume of 82,328 shares.The stock last traded at $70.09 and had previously closed at $70.86. ESTA has been the topic of several recent analyst reports. The []

Establishment Labs Holdings Inc. (NASDAQ:ESTA)s share price traded down 5.8% on Friday . The company traded as low as $60.32 and last traded at $60.32. 2,265 shares were traded during mid-day trading, a decline of 98% from the average session volume of 99,694 shares. The stock had previously closed at $64.05. A number of research []

Establishment Labs (NASDAQ:ESTA) had its price target raised by Stephens from $88.00 to $90.00 in a research note released on Wednesday, Analyst Ratings Network reports. They currently have an overweight rating on the stock. Other equities analysts also recently issued research reports about the company. The Goldman Sachs Group upped their price objective on Establishment []

Establishment Labs Holdings' (ESTA) CEO Juan José Chacón Quirós on Q3 2021 Results - Earnings Call Transcript

SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast a

SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast a